We are live on
!
Find out more
LNAI
Lunai Bioworks
LNAI
LNAI
20 hedge funds and large institutions have $1.38M invested in Lunai Bioworks in 2025 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
0.04% less ownership
Funds ownership: 0.1% → 0.06% (-0.04%)
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
52% less funds holding
Funds holding: 42 → 20 (-22)
67% less capital invested
Capital invested by funds: $4.17M → $1.38M (-$2.79M)
88% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 25
Holders
20
Holders Change
-22
Holders Change %
-52.38%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
7
Closed
25
Calls
$53K
Puts
–
Net Calls
+$53K
Net Calls Change
+$22K
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$91K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$60.6K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$60.1K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$60K |
| 5 |
Two Sigma Investments
New York
|
+$39.6K |
Top Sellers
| 1 |
BlackRock
New York
|
-$343K |
| 2 |
Jane Street
New York
|
-$258K |
| 3 |
Goldman Sachs
New York
|
-$109K |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$89.7K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$66.1K |
